Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:2729:55-64.
doi: 10.1007/978-1-0716-3499-8_5.

Preparation of [68Ga]GaCl3 Using a Cyclotron

Melissa E Rodnick  1 , Carina Sollert  2 , D Christian Parr  2 , Jens Frigell  2 , Katherine Gagnon  3 , Peter J H Scott  1
Affiliations

Preparation of [68Ga]GaCl3 Using a Cyclotron

Melissa E Rodnick et al. Methods Mol Biol. 2024.

Abstract

Recent developments in 68Ga-radiopharmaceuticals, including a number of regulatory approvals for clinical use, has created a hitherto unprecedented demand for 68Ga. Reliable access to enough 68Ga to meet growing clinical demand using only 68Ge/68Ga generators has been problematic in recent years. To address this challenge, we have optimized the direct production of 68Ga on a cyclotron via the 68Zn(p,n)68Ga reaction using a liquid target. This protocol describes the cyclotron-based production of [68Ga]GaCl3 implemented at the University of Michigan using a liquid target on GE PETtrace instrumentation. The protocol provides 56 ± 4 mCi (n = 3) of [68Ga]GaCl3 that meets the necessary quality control criteria to use for the preparation of 68Ga-radiopharmaceuticals for human use.

Keywords: Cyclotron-produced gallium-68; Gallium-68; PSMA-11; Radiotheranostics.

PubMed Disclaimer

References

    1. Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, Baumann M, Gambhir SS, Hricak H, Weissleder R (2020) Radiotheranostics: a roadmap for future development. Lancet Oncol 21:e146–e156 - DOI
    1. Qaim SM, Scholten B, Neumaier B (2018) New developments in the production of theranostic pairs of radionuclides. J Radioanal Nucl Chem 318:1493–1509 - DOI
    1. Pencharz D, Gnanasegaran G, Navalkissoor S (2018) Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy. Br J Radiol 91:20180108 - DOI
    1. FDA approves new diagnostic imaging agent to detect rare neuroendocrine tumors. [new release]. https://www.fda.gov/news-events/press-announcements/fda-approves-new-dia... . Published 1 Jun 2016; Accessed 2 Jun 2021
    1. Sunderland JJ (2020) The Academic NDA: justification, process, and lessons learned. J Nucl Med 61:480–487 - DOI

LinkOut - more resources